T-cell lymphoblastic lymphoma with extensive thrombi and cardiac thrombosis: A case report and review of literature

Table 1 Therapy course

Date	Low-molecular-weight heparin	Pegaspargase	Cyclophosphamide	Pegylated liposomal doxorubicin	Vindesine	Dexamethasone	Methotrexate	Chidamide
July 16-July 19	5000 U/d					5 mg/d
July 20-July 26		3750 IU × 1 d	1.2 g × 1 d	20 mg/d × 3 d	4 mg × 1 d	10 mg/d × 7 d
August 23-August 29		3750 IU × 1 d	1.0 g × 1 d	20 mg/d × 3 d	4 mg × 1 d	10 mg/d × 7 d	2 g × 1 d
September 20								30 mg 2/wk (follow up for half year)

Table 2 The table of accessory examination

Date	Echocardiography (cardiac thrombus in the right atrium)	Bone marrow cytology	Flow cytometry	CTA of head	CT of head
July 16	52.3 mm × 42.1 mm	The abnormal lymphocytes accounted for 79%	Abnormal T lymphoblasts accounted for 85.5%
July 20	50 mm × 42 mm
July 27	42 mm × 38 mm
August 3	35 mm × 28 mm
August 9	28 mm × 22 mm
August 15	25 mm × 13 mm
August 22	22.8 mm × 15 mm	The abnormal lymphocytes accounted for 4%	Abnormal T lymphoblasts accounted for 5.21%
August 30	18 mm × 15 mm
September 3	None			A large area of low-density shadow in the right parietal lobe, which was considered a cerebral infarction
September 6					On the right frontal and parietal lobes, there were low-density patches with slightly higher density. On contrast-enhanced scans, slight enhancement could be seen, indicating the possibility of cerebral infarction with a small amount of hemorrhage

CT: Computed tomography; CTA: Computed tomography angiography.